Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-i... by Muro, Kei, Dr, Boku, Narikazu, MD, Shimada, Yasuhiro, MD, Tsuji, Akihito, MD, Sameshima, Shinichi, MD, Baba, Hideo, Prof, Satoh, Taroh, MD, Denda, Tadamichi, MD, Ina, Kenji, MD, Nishina, Tomohiro, MD, Yamaguchi, Kensei, MD, Takiuchi, Hiroya, Prof, Esaki, Taito, MD, Tokunaga, Shinya, MD, Kuwano, Hiroyuki, Prof, Komatsu, Yoshito, MD, Watanabe, Masahiko, Prof, Hyodo, Ichinosuke, Prof, Morita, Satoshi, Prof, Sugihara, Kenichi, Prof

Get full text

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial by Grothey, Axel, MD, Cutsem, Eric Van, Prof, Sobrero, Alberto, MD, Siena, Salvatore, MD, Falcone, Alfredo, MD, Ychou, Marc, MD, Humblet, Yves, MD, Bouché, Olivier, MD, Mineur, Laurent, MD, Barone, Carlo, MD, Adenis, Antoine, MD, Tabernero, Josep, MD, Yoshino, Takayuki, MD, Lenz, Heinz-Josef, MD, Goldberg, Richard M, MD, Sargent, Daniel J, PhD, Cihon, Frank, MS, Cupit, Lisa, MD, Wagner, Andrea, MD, Laurent, Dirk, DrMed

Get full text